168 related articles for article (PubMed ID: 2055205)
21. Effect of the 5 alpha-reductase inhibitor PNU 156765, alone or in combination with flutamide, in the Dunning R3327 prostatic carcinoma model in rats.
Zaccheo T; Giudici D; Panzeri A; di Salle E
Chemotherapy; 1998; 44(4):284-92. PubMed ID: 9681205
[TBL] [Abstract][Full Text] [Related]
22. 4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor.
Liang T; Heiss CE; Cheung AH; Reynolds GF; Rasmusson GH
J Biol Chem; 1984 Jan; 259(2):734-9. PubMed ID: 6693392
[TBL] [Abstract][Full Text] [Related]
23. Antiandrogenic effects in short-term in vivo studies of the fungicide fenarimol.
Vinggaard AM; Jacobsen H; Metzdorff SB; Andersen HR; Nellemann C
Toxicology; 2005 Feb; 207(1):21-34. PubMed ID: 15590119
[TBL] [Abstract][Full Text] [Related]
24. Consideration of the use of 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5- alpha-androstan-3-one (4MA), a 5 alpha-reductase inhibitor, in prostate cancer therapy.
Geldof AA; Meulenbroek MF; Dijkstra I; Bohlken S; Rao BR
J Cancer Res Clin Oncol; 1992; 118(1):50-5. PubMed ID: 1729259
[TBL] [Abstract][Full Text] [Related]
25. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors.
Liang T; Rasmusson GH; Brooks JR
J Steroid Biochem; 1983 Jul; 19(1A):385-90. PubMed ID: 6887871
[TBL] [Abstract][Full Text] [Related]
26. Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductase.
Kadohama N; Wakisaka M; Kim U; Karr JP; Murphy GP; Sandberg AA
J Natl Cancer Inst; 1985 Feb; 74(2):475-86. PubMed ID: 3856054
[TBL] [Abstract][Full Text] [Related]
27. Effects of sex steroids on regulation of the levels of C1 peptide of rat prostatic steroid-binding protein mRNA evaluated by in-situ hybridization.
Pelletier G; Labrie C; Simard J; Duval M; Martinoli MG; Zhao H; Labrie F
J Mol Endocrinol; 1988 Nov; 1(3):213-23. PubMed ID: 2475128
[TBL] [Abstract][Full Text] [Related]
28. Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostate.
Marchetti B; Poulin R; Plante M; Labrie F
J Steroid Biochem; 1988 Oct; 31(4A):411-9. PubMed ID: 2845194
[TBL] [Abstract][Full Text] [Related]
29. Effects of estradiol on prostate epithelial cells in the castrated rat.
Pelletier G
J Histochem Cytochem; 2002 Nov; 50(11):1517-24. PubMed ID: 12417618
[TBL] [Abstract][Full Text] [Related]
30. Anti-androgen effects of the aromatase inhibitor, atamestane.
Shao TC; Marcelli M; Kong A; Cunningham GR
J Androl; 1995; 16(2):100-7. PubMed ID: 7559139
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
Dadras SS; Cai X; Abasolo I; Wang Z
Gene Expr; 2001; 9(4-5):183-94. PubMed ID: 11444528
[TBL] [Abstract][Full Text] [Related]
32. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
[TBL] [Abstract][Full Text] [Related]
33. Androgen-independent epithelial cells of the rat ventral prostate.
Montpetit M; Abrahams P; Clark AF; Tenniswood M
Prostate; 1988; 12(1):13-28. PubMed ID: 3347595
[TBL] [Abstract][Full Text] [Related]
34. Basis for hormonal management of advanced prostate cancer.
Geller J
Cancer; 1993 Feb; 71(3 Suppl):1039-45. PubMed ID: 7679038
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of flutamide action on prostatic and testicular functions in the rat.
Marchetti B; Labrie F
J Steroid Biochem; 1988 Jun; 29(6):691-8. PubMed ID: 2838689
[TBL] [Abstract][Full Text] [Related]
36. In vitro effects of an aromatase inhibitor on 5 alpha-reductase activity in human hypertrophic prostatic tissue.
Zoppi S; Cocconi M; Natali A; Costantini A; Serio M; Martini L; Motta M
J Clin Endocrinol Metab; 1986 Jul; 63(1):269-71. PubMed ID: 2423549
[TBL] [Abstract][Full Text] [Related]
37. Effect of 5-alpha-reductase inhibition and dexamethasone administration on the growth characteristics and intratumor androgen levels of the human prostate cancer cell line PC-3.
Tuttle RM; Loop S; Jones RE; Meikle AW; Ostenson RC; Plymate SR
Prostate; 1994 May; 24(5):229-36. PubMed ID: 8170835
[TBL] [Abstract][Full Text] [Related]
38. Effects of androgen and antiandrogen treatment on canine prostatic arginine esterase.
Juniewicz PE; Barbolt TA; Egy MA; Frenette G; Dube JY; Tremblay RR
Prostate; 1990; 17(2):101-11. PubMed ID: 2169047
[TBL] [Abstract][Full Text] [Related]
39. Action of prolactin in regressing prostate: independent of action mediated by androgen receptors.
Assimos D; Smith C; Lee C; Grayhack JT
Prostate; 1984; 5(6):589-95. PubMed ID: 6494057
[TBL] [Abstract][Full Text] [Related]
40. Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride.
Geller J; Sionit L
J Cell Biochem Suppl; 1992; 16H():109-12. PubMed ID: 1283893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
